RecruitingPhase 3NCT06585787A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb companyAustin, TX · Dallas, TX · DeSoto, TX · +99 more sites
RecruitingPhase not listedNCT07379827Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)Sponsor: Bristol-Myers SquibbAustin, TX · Dallas, TX · Fort Worth, TX · +52 more sites
RecruitingPhase 3NCT06961968Randomized Withdrawal Study in Patients With SchizophreniaSponsor: Vanda PharmaceuticalsAustin, TX · Houston, TX · Irving, TX · +19 more sites